Contract 36E79725A0003
Ascendis Pharma, Inc. · Department Of Veterans Affairs · February 3, 2025
Ascendis Pharma, Inc. was awarded a federal contract by Department Of Veterans Affairs on February 3, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79722D0166. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 2, 2026. If all options are exercised, the contract could reach $18.00 million.
Contract details
- PIID
- 36E79725A0003
- Parent IDIQ
- 36F79722D0166
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- February 3, 2025
- Latest action
- July 2, 2026
Description
BPA CANCELLATION
Modification timeline
-
July 2, 2026Mod P00005 · Legal Contract Cancellation$0
-
January 5, 2026Mod P00004 · Exercise An OptionEXERCISE OPTION YEAR 1$0
-
December 23, 2025Mod P00003 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW PRICING UPDATES.$0
-
November 18, 2025Mod P00002 · Supplemental Agreement For Work Within ScopeSKYTROFA PRODUCT ADDITION$0
-
July 8, 2025Mod P00001 · Other Administrative ActionCORRECT COMPANY NAME AND UPDATE POC$0
-
February 3, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79725A0003?
Contract 36E79725A0003 is a federal contract awarded to Ascendis Pharma, Inc. by Department Of Veterans Affairs on February 3, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 36E79725A0003?
Ascendis Pharma, Inc. won contract 36E79725A0003 from Department Of Veterans Affairs.
How much is contract 36E79725A0003 worth?
Contract 36E79725A0003 has obligated $0 to date but carries a potential ceiling of $18.00 million if fully funded and all options are exercised.